Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Johnson & Johnson

JNJ
Current price
155.75 USD -1.13 USD (-0.72%)
Last closed 156.88 USD
Sector Healthcare
Industry Drug Manufacturers-General
Exchange NYSE
Capitalization 386 485 616 640 USD
Yield for 12 month -4.56 %
Week
Month
Year
JNJ
21.11.2021 - 28.11.2021

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Address: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

Analytics

WallStreet Target Price

169.76 USD

P/E ratio

32.5558

Dividend Yield

2.94 %

Current Year

+94 943 000 000 USD

Last Year

+93 775 000 000 USD

Current Quarter

+25 530 000 000 USD

Last Quarter

+24 746 000 000 USD

Current Year

+63 854 000 000 USD

Last Year

+63 920 000 000 USD

Current Quarter

+17 318 000 000 USD

Last Quarter

+16 351 000 000 USD

Key Figures JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 34 313 000 960 USD
Operating Margin TTM 27.66 %
PE Ratio 32.5558
Return On Assets TTM 9.15 %
PEG Ratio 3.7929
Return On Equity TTM 17.09 %
Wall Street Target Price 169.76 USD
Revenue TTM 97 773 002 752 USD
Book Value 28.92 USD
Revenue Per Share TTM 37.44 USD
Dividend Share 4.58 USD
Quarterly Revenue Growth YOY 6.3 %
Dividend Yield 2.94 %
Gross Profit TTM 63 954 000 000 USD
Earnings Share 4.93 USD
Diluted Eps TTM 4.93 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY 8.9 %
Profit Margin 13.35 %

Dividend Analytics JNJ

Aristocrat - 25 or more consecutive years of dividend increases

Dividend growth over 5 years

34 %

Continuous growth

38 years

Payout Ratio 5 years average

64 %

Dividend History JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 4.76
Ex Dividend Date 25.08.2023
Forward Annual Dividend Yield 2.94 %
Last Split Factor 2:1
Payout Ratio 44.7 %
Last Split Date 13.06.2001
Dividend Date 07.09.2023

Stock Valuation JNJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 32.5558
Forward PE 16.8919
Enterprise Value Revenue 4.7627
Price Sales TTM 4.8935
Enterprise Value EBITDA 15.4742
Price Book MRQ 6.1592

Financials JNJ

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators JNJ

For 52 weeks

147.91 USD 177.12 USD
50 Day MA 166.46 USD
Shares Short Prior Month 25 728 797
200 Day MA 164.15 USD
Short Ratio 0.71
Shares Short 32 863 484
Short Percent 1.37 %